New HIV prevention findings delay release of WHO guidelines for discordant couples

"Upbeat new HIV prevention findings presented last week at an international AIDS conference held in Rome have complicated attempts by the World Health Organization (WHO) to draft much-anticipated guidelines for heterosexual couples in which one partner is infected," ScienceInsider reports.

WHO had planned to release guidelines for discordant couples, which it had been working on for months, at the conference, but pulled them at the last minute after consulting "a range of partners," including UNAIDS and the Bill & Melinda Gates Foundation, according to Gottfried Hirnschall, head of the WHO HIV/AIDS department, the news service notes. "In particular, the partners had concerns about both the language in the document and its lack of inclusion of" findings from the HPTN 052 and Partners PrEP clinical trials, ScienceInsider writes (Cohen, 7/25).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New two-dose HIV vaccine strategy shows promise for stronger immune response